ALOPECIA AREATA (AA)
Clinical trials for ALOPECIA AREATA (AA) explained in plain language.
Never miss a new study
Get alerted when new ALOPECIA AREATA (AA) trials appear
Sign up with your email to follow new studies for ALOPECIA AREATA (AA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early trial tests new drug for autoimmune hair loss
Disease control CompletedThis early-stage study tested the safety and potential effectiveness of an experimental drug called IMG-007 for adults with significant hair loss from alopecia areata. A small group of 29 participants received three intravenous infusions of the drug over four weeks. Researchers m…
Matched conditions: ALOPECIA AREATA (AA)
Phase: PHASE1, PHASE2 • Sponsor: Inmagene LLC • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Scientists search for genetic clue to hair loss condition
Knowledge-focused CompletedThis study aimed to understand if a specific variation in a gene involved in immune response is linked to developing alopecia areata and how severe it becomes. Researchers compared the genes of 120 adults with alopecia areata to healthy individuals. The goal was to gather knowled…
Matched conditions: ALOPECIA AREATA (AA)
Sponsor: Benha University • Aim: Knowledge-focused
Last updated Mar 20, 2026 14:48 UTC